Coronavirus Drug Could Cost 750% More Than a Flu Shot

A potential coronavirus treatment developed by Gilead Sciences won’t come cheap. The resource-constrained developing world would be especially hard hit if the respiratory illness gets out of control. Biotech stocks have enjoyed a rally in the wake of the outbreak. Coronavirus has been, rightly or wrongly, compared to the flu based on a similar set […]

Continue Reading